Founder & CEO

Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand

In Tough Climate for Raising Money, VC Firm Hatteras Secures $200M for Two New Funds

Actithera closes $75.5m Series A to advance radioligand therapy platform

Norway & US-based Actithera raises $75.5M Series A to advance radioligand therapy pipeline

Senior Director / Vice President, Chief of Staff & Head of Strategy

Actithera is an emerging leader in radiopharmaceutical therapeutics, advancing a differentiated platform to address high-value oncology targets. They are seeking a highly strategic and versatile leader to serve as Chief of Staff & Head of Strategy, partnering with the CEO to define and execute R&D, clinical, and business development strategies while ensuring operational execution of key initiatives.

Sign up with Google

Sign in with Google